Novel paradigms for drug discovery: computational multitarget screening.

Area of Science:

• Computational biology
• Drug discovery and development
• Infectious diseases

Background:

• Current drug development relies on identifying single protein targets and extensive experimental screening, which is inefficient and costly.
• This traditional approach involves trial-and-error, posing risks and significant time and financial investments.
• Challenges in treating complex drug-resistant diseases necessitate more efficient therapeutic strategies.

Purpose of the Study:

• To introduce a computational (virtual) drug discovery pipeline for more efficient identification of lead inhibitors.
• To explore the benefits of simultaneously screening compounds against multiple protein targets, considering protein-inhibitor dynamics.
• To demonstrate the application of this virtual approach using HIV-1 and Plasmodium falciparum infections as case studies.

Main Methods:

• Utilizing computational screening of drug-like compounds against multiple atomic structures of protein targets.
• Incorporating protein-inhibitor dynamics into the virtual screening process.
• Developing a virtual drug discovery pipeline for lead identification and toxicity prediction.

Main Results:

• Virtual screening offers a more efficient method for identifying lead inhibitors compared to traditional experimental approaches.
• The proposed pipeline can simultaneously assess multiple targets, potentially accelerating the discovery of treatments for complex diseases.
• This computational strategy may help minimize drug side-effects and toxicity.

Conclusions:

• A virtual drug discovery pipeline, incorporating multi-target screening and dynamics, can significantly enhance the efficiency of identifying potential drug candidates.
• This approach holds promise for developing more effective therapies for challenging diseases like HIV-1 and malaria.
• Virtual screening has the potential to reduce the risks, time, and costs associated with traditional drug development, leading to more successful therapies.